WCG Clinical, Inc.

WCGC

US92941R1095

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2021	WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans	RE
2021	WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans	RE

WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.

October 13, 2021 at 12:00 am EDT

WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.

Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 45,000,000
PriceRange: $15 to $17

Latest news about WCG Clinical, Inc.

WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans	21-10-13	RE
WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans	21-10-13	RE
WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.	21-10-13	CI
WCG Clinical, Inc. acquired VeraSci for $330 million.	21-07-25	CI
WCG Clinical, Inc. has filed an IPO in the amount of $100 million.	21-07-01	CI
WCG Clinical, Inc. acquired Intrinsic Imaging LLC for $92.1 million.	21-06-30	CI
Da Vinci Purchaser Corp completed the acquisition of WCG Holding IV Inc. and WCG Market Intelligence & Insights Inc. from WCG Holding IV LLC.	20-01-07	CI
Da Vinci Purchaser Corp entered into an agreement to acquire WCG Holding IV Inc. and WCG Market Intelligence & Insights Inc. from WCG Holding IV LLC for $3.2 billion.	19-11-05	CI

WCG Clinical Holdings Inc is a United States-based company. The Company is a provider of clinical trial solutions. It is focused on providing solutions that are designed to improve clinical research. Its solutions help biopharmaceutical companies, contract research organizations, and institutions for delivery of new treatments and therapies to patients. It is organized into two segments: Ethical Review (ER) segment and Clinical Trial Solutions segment. The ER segment provides technology-enabled services that ensure clinical trials respect the rights and protect the welfare of patient participants. ER segment also provides a hosted software application to its clients. Clinical Trial Solutions (CTS) segment provides technology-enabled solutions that support the conduct of effective clinical trials, including study planning and site optimization, patient engagement, and scientific and regulatory review.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
WCG CLINICAL, INC.	-.--%	6.07B
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research

WCG Clinical, Inc.

Equities

WCGC

US92941R1095

Biotechnology & Medical Research

WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.

Latest news about WCG Clinical, Inc.

Chart WCG Clinical, Inc.

Company Profile

Sector Other Biotechnology & Medical Research